About this trial
This prospective multicenter observational study aims to evaluate the predictive value of artificial intelligence-based analysis of preoperative 12-lead electrocardiography for myocardial injury after non-cardiac surgery (MINS) and major adverse cardiovascular events (MACE) within 30 days after surgery in patients undergoing non-cardiac surgery for urologic cancer.
Eligibility criteria
Qualifiers
Age ≥ 60 years
Patients scheduled for major non-cardiac surgery under general anesthesia due to urologic cancer (e.g., radical prostatectomy, radical nephrectomy, partial nephrectomy)
Patients who undergo preoperative standard 12-lead electrocardiography
Patients classified as having intermediate or higher surgical risk
Disqualifiers
History of major adverse cardiovascular events (MACE) within 6 months prior to surgery
Inability to obtain essential clinical information required for study participation and follow-up
Patients who are not hospitalized after surgery
Individuals deemed inappropriate for participation in the study by the investigator due to legal or psychiatric reasons
Trial design
Treatments tested in this trial
- No intervention assigned
Treatment groups
Locations
Sponsors and collaborators
Korea University Anam Hospital
Lead sponsor
The Catholic University of Korea
Collaborator
Keimyung University Dongsan Medical Center
Collaborator
Medical AI Co., Ltd
Collaborator